303 Broadway, Suite 1100,
Cincinnati , OH, 45202-4203

Rank

Rank Universe

Summary

The fund seeks capital appreciation in the long term by investing in companies across any size outside the United States.

The sub-adviser’s investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team focuses on stocks of established companies located in or that con More

Link

Directors

Sep 8, 2023
  • E. Blake Moore, Jr.
  • Susan M. King
  • William H. Zimmer III
  • Karen Carnahan
  • Kevin A. Robie
  • Sally J. Staley
  • William C. Gale
  • Jill T. McGruder

Chief Compliance Officer

  • Timothy S. Stearns

Fund Manager(s)

Price

  • $ 16.4 ( +0.05 )
    Nov 4, 2024
    Last Close
  • Net Assets
  • $116.3M
    Feb 28, 2024
  • Holding
  • 81
    Aug 26, 2024
    More

  • 52-Week High/Low
  • $17 - $14.12
  • Turnover
  • 45%
  • Expense Ratio
  • 1.41%

Company Name

Holding

Novartis AG 2.64 %
Hon Hai Precision Industry Co Ltd. 2.18 %
Dreyfus Government Cash Management Funds 1.94 %
Britvic PLC 1.92 %
Roche Holdings AG 1.76 %
GSK plc 1.54 %
Manulife Financial Corporation 1.5 %
Munich Reinsurance AG 1.47 %
Tesco PLC 1.47 %
Investec PLC 1.43 %
More 1.43 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

-9.99%

5 Year

2.69%

Best

33.8%

2009

Worst

-43.04%

2008

Alpha

SWRLX S&P 500

Chart +